Table 4.

Antioxidant and Anti-Hialuronidase Activities.

No.	DPPH IC50 (mg/mL)	ABTS IC50 (mg/mL)	CUPRAC IC50 (mg/mL)	FRAP IC50 (mg/mL)	Hyaluronidase Inhibition IC50 (mg/mL)
Mean ± SD
W1	0.80 ± 0.02	0.66 ± 0.08	2.16 ± 0.02	0.49 ± 0.03	73.52 ± 2.37
W2	0.65 ± 0.01	0.49 ± 0.04	1.63 ± 0.03	0.30 ± 0.01	44.02 ± 1.48
W3	0.50 ± 0.01	0.42 ± 0.04	1.33 ± 0.30	0.29 ± 0.01	33.21 ± 2.40
W4	0.45 ± 0.01	0.44 ± 0.04	0.45 ± 0.02	0.23 ± 0.01	25.45 ± 0.87
W5	0.31 ± 0.02	0.38 ± 0.03	0.30 ± 0.02	0.18 ± 0.01	19.98 ± 1.67
W6	0.25 ± 0.01	0.31 ± 0.02	0.27 ± 0.03	0.13 ± 0.01	11.34 ± 2.45
W7	0.22 ± 0.03	0.21 ± 0.04	0.19 ± 0.01	0.14 ± 0.01	10.43 ± 1.33
W8	0.16 ± 0.02	0.18 ± 0.02	0.13 ± 0.01	0.11 ± 0.01	4.69 ± 0.33
W9	0.13 ± 0.01	0.14 ± 0.01	0.11 ± 0.01	0.09 ± 0.01	4.35 ± 0.28
	IC50 (µg/mL)	IC50 (µg/mL)	IC50 (µg/mL)	IC50 (µg/mL)
Resveratrol	22.32 ± 0.20	10.84 ± 0.23	20.82 ± 1.29	9.17 ± 0.68
Polydatin	35.06 ± 1.11	25.21 ± 2.32	68.73 ± 0.48	12.90 ± 0.29